These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5028220)

  • 21. AO44: an improved hyperglycemic agent.
    Lopez N; Basabe J; Grant A; Krees S; Terry M; Viktora J; Wolff F
    Metabolism; 1971 Apr; 20(4):373-83. PubMed ID: 5550304
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hypoglycemic sulfonamides].
    Loubatières AL
    Actual Pharmacol (Paris); 1968; 21():173-90. PubMed ID: 4888764
    [No Abstract]   [Full Text] [Related]  

  • 23. [Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].
    Loubatières A
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():216-55. PubMed ID: 4906020
    [No Abstract]   [Full Text] [Related]  

  • 24. Mode of action of a diazoxide analog (A025). Its effects on insulin secretion.
    Grant AM; Basabe JC; Lopez NL; Krees SV; Wolff FW
    Diabetes; 1970 Sep; 19(9):630-8. PubMed ID: 4990295
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antagonistic action of intestinal hormones and diazoxide on insulin secretion in humans].
    Raptis S; Schröder KE; Faulhaber JD; Pfeiffer EF
    Horm Metab Res; 1969 May; 1(3):116-21. PubMed ID: 4946718
    [No Abstract]   [Full Text] [Related]  

  • 26. [Proceedings: Cellular calcium and insulin secretion. Morphologic studies of B-cells in the mouse following tolbutamide and diazoxide administration].
    Schäfer HJ; Klöppel G
    Verh Dtsch Ges Pathol; 1974; 58():490. PubMed ID: 4618000
    [No Abstract]   [Full Text] [Related]  

  • 27. [Morphology and histochemistry of insulin secretion].
    Creutzfelt W
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():387-416. PubMed ID: 4313827
    [No Abstract]   [Full Text] [Related]  

  • 28. A difference in mechanism by which leucine and other amino acids induce insulin release.
    Fajans SS; Floyd JC; Knopf RF; Guntsche EM; Rull JA; Thiffault CA; Conn JW
    J Clin Endocrinol Metab; 1967 Nov; 27(11):1600-6. PubMed ID: 4294681
    [No Abstract]   [Full Text] [Related]  

  • 29. The direct effect of oral hypoglycaemic agents on glucose metabolism by adipose tissue.
    Elkeles RS
    Horm Metab Res; 1972 May; 4(3):178-82. PubMed ID: 5044228
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparison of the beta-cytotropic effect of glymidine sodium (glycodiazine), glucagon, and isopropylnoradrenaline in rats].
    Losert W; Loge O; Jahn P
    Arzneimittelforschung; 1973 Sep; 23(9):1251-60. PubMed ID: 4149442
    [No Abstract]   [Full Text] [Related]  

  • 31. [Quantitative pharmacodynamics with an endocrine cell: sulfonylureas and insulin secretion].
    Alric R; Portal A
    Therapie; 1969; 24(5):871-80. PubMed ID: 5364207
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of diazoxide on insulin secretion and metabolic efficiency in the db/db mouse.
    Lee S
    Life Sci; 1981 Apr 13-20; 28(15-16):1829-40. PubMed ID: 7017329
    [No Abstract]   [Full Text] [Related]  

  • 33. Leptin fully suppresses acetylcholine-induced insulin secretion and is reversed by tolbutamide in isolated perfused chicken pancreas.
    Benomar Y; Rideau N; Crochet S; Derouet M; Taouis M
    Horm Metab Res; 2003 Feb; 35(2):81-5. PubMed ID: 12734786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of insulin secretion by alpha adrenergic stimulatory agents].
    Senft G; Sitt R; Losert W; Schultz G; Hoffmann M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(4):309-23. PubMed ID: 4300750
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas.
    Laube H; Fussgänger R; Goberna R; Schröder K; Straub K; Sussman K; Pfeiffer EF
    Horm Metab Res; 1971 Jul; 3(4):238-42. PubMed ID: 4256979
    [No Abstract]   [Full Text] [Related]  

  • 36. Diazoxide effects on biphasic insulin release: "adrenergic" suppression and enhancement in the perifused rat pancreas.
    Burr IM; Marliss EB; Stauffacher W; Renold AE
    J Clin Invest; 1971 Jul; 50(7):1444-50. PubMed ID: 5090060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Action of tolbutamide on glucagon secretion. I. Study in anesthesitized dogs].
    Loubatiéres AL; Loubatiéres-Mariani MM; Ribes G; Alric R
    C R Seances Soc Biol Fil; 1972; 166(12):1757-60. PubMed ID: 4665276
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin-related changes in the subcellular distribution of insulin receptors in intact rat liver: effects of acute hypoinsulinemia induced by diazoxide, somatostatin, and xylazine.
    López S; Desbuquois B
    Endocrinology; 1987 May; 120(5):1695-702. PubMed ID: 2882996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of diazoxide on insulin secretion in vitro.
    Howell SL; Taylor KW
    Lancet; 1966 Jan; 1(7429):128-9. PubMed ID: 4158956
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on carbohydrate metabolism in penguins (Pygocellis papua).
    Chieri RA; Basabe JC; Farina JM; Foglia VG
    Gen Comp Endocrinol; 1972 Feb; 18(1):1-4. PubMed ID: 5009675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.